Dr. Reddys Laboratories Ltd.

Pharmaceuticals & Drugs
Coming Soon
2825.00
Price at 7:57 AM

Performance

Dr. Reddys Laboratories Ltd.

Open Price₹2,817.90
Today's High₹2,838.00
52W High₹2,965.20
Deliverables2.82%
Prev. Close₹2,812.35
Today's Low₹2,756.10
52W Low₹2,065.30
Volume10022

Fundamentals

Market Cap
₹46,355 Cr
EPS(TTM)
₹129.43
Book Value
₹879.01
Face Value
₹5.00
Industry P/E
16.49
P/E
23.75
P/B
3.17
Div. Yield
0.72%

About the Company

Dr. Reddys Laboratories Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1984. The current market capitalisation stands Rs 46726 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 500124. and also listed on National Stock Exchange (NSE) with NSE code as DRREDDY.
Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. It also provides a portfolio of in-licensed dermatology products. As of March 31, 2018, this segment had 13 active products development programs pipeline that are in various stages of development. The company’s therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, pain management, oncology, dermatology, urology, and nephrology. It has collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology; and collaboration agreement with Merck Serono to co-develop a portfolio of biosimilar compounds in oncology, primarily focused on monoclonal antibodies. Dr. Reddy's Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.
... Read More
Organisation
Dr. Reddys Lab
Founded Year
1984
Managing Director
GV Prasad

Market Updates

News
Events
Not available currently
ⓒ 2019 Billionbrains Garage Ventures Pvt Ltd